These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


687 related items for PubMed ID: 23468514

  • 1. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Joyce E, Hoogslag GE, Leong DP, Fox K, Schalij MJ, Marsan NA, Bax JJ, Delgado V.
    Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
    [Abstract] [Full Text] [Related]

  • 2. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 3. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D, Zhong W, Fan L, Chen L.
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [Abstract] [Full Text] [Related]

  • 4. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, de Caralt TM, Heras M, Bosch X, Azqueta M, Pare C, Brugada J.
    Am J Cardiol; 2009 Oct 01; 104(7):878-82. PubMed ID: 19766750
    [Abstract] [Full Text] [Related]

  • 5. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS.
    Arterioscler Thromb Vasc Biol; 2013 Sep 01; 33(9):2252-60. PubMed ID: 23868944
    [Abstract] [Full Text] [Related]

  • 6. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ørn S, Ueland T, Manhenke C, Sandanger Ø, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P.
    J Intern Med; 2012 Sep 01; 272(3):267-76. PubMed ID: 22243053
    [Abstract] [Full Text] [Related]

  • 7. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, Bootsma M, Zeppenfeld K, van der Laarse A, Atsma DE, Jukema JW, Schalij MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):335-43. PubMed ID: 19642182
    [Abstract] [Full Text] [Related]

  • 8. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.
    Boden H, Ahmed TA, Velders MA, van der Hoeven BL, Hoogslag GE, Bootsma M, le Cessie S, Cobbaert CM, Delgado V, van der Laarse A, Schalij MJ.
    Am J Cardiol; 2013 May 15; 111(10):1387-93. PubMed ID: 23465094
    [Abstract] [Full Text] [Related]

  • 9. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L, Bilato C, Osto E, Cademartiri F, Musumeci G, Corbetti F, Razzolini R, Iliceto S.
    Coron Artery Dis; 2010 Mar 15; 21(2):78-86. PubMed ID: 20071979
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction.
    Kitabata H, Kubo T, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kashiwagi M, Ozaki Y, Shiono Y, Shimamura K, Orii M, Hirata K, Tanaka A, Imanishi T, Akasaka T.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1046-54. PubMed ID: 24156965
    [Abstract] [Full Text] [Related]

  • 11. Repolarization parameters in patients with acute ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention with respect to predischarge ST-T pattern: a preliminary study.
    Szydło K, Wita K, Trusz-Gluza M, Zawada K, Piecuch A, Kulach A, Kucz E, Tyrka A, Kornacka I, Trams-Stawowska P, Pieda G.
    Cardiol J; 2009 Oct 15; 16(1):52-6. PubMed ID: 19130416
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Changes in Global Longitudinal Peak Systolic Strain After ST-Segment Elevation Myocardial Infarction in Patients With Versus Without Diabetes Mellitus.
    Hoogslag GE, Abou R, Joyce E, Boden H, Kamperidis V, Regeer MV, van Rosendael PJ, Schalij MJ, Bax JJ, Marsan NA, Delgado V.
    Am J Cardiol; 2015 Nov 01; 116(9):1334-9. PubMed ID: 26341185
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
    Antoni ML, Hoogslag GE, Boden H, Liem SS, Boersma E, Fox K, Schalij MJ, Bax JJ, Delgado V.
    Am J Cardiol; 2012 Jan 15; 109(2):187-94. PubMed ID: 22244127
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA, Lopez-Haldon JE, Fernandez M, Mancha F, Sanchez A, Rodriguez-Puras MJ, Villa M, Lopez-Pardo F, Diaz de la Llera L, Valle JI, Martinez A.
    Heart; 2012 Aug 15; 98(15):1153-9. PubMed ID: 22572051
    [Abstract] [Full Text] [Related]

  • 15. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB, Ottervanger JP, Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT, Suryapranata H, van 't Hof AW.
    Coron Artery Dis; 2009 Jan 15; 20(1):9-14. PubMed ID: 19050596
    [Abstract] [Full Text] [Related]

  • 16. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM, Kim S, Chang K, Min J, Kim TH, Koh YS, Park HJ, Shin WS, Lee JM, Kim PJ, Chung WS, Seung KB.
    Coron Artery Dis; 2011 Jan 15; 22(6):405-10. PubMed ID: 21701385
    [Abstract] [Full Text] [Related]

  • 17. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.
    Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, Katus HA, Korosoglou G.
    J Intern Med; 2011 Sep 15; 270(3):245-53. PubMed ID: 21362071
    [Abstract] [Full Text] [Related]

  • 18. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T, Iyisoy A, Yuksel CU, Kilic S, Yilmaz MI, Akgul EO, Jata B, Isik E.
    Coron Artery Dis; 2008 Dec 15; 19(8):543-9. PubMed ID: 19005288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of ST-segment elevation resolution after primary coronary angioplasty in predicting early and late left ventricular function in patients with anterior acute myocardial infarction].
    Araszkiewicz A, Lesiak M, Grajek S, Mularek-Kubzdela T, Popiel M, Cieśliński A.
    Pol Merkur Lekarski; 2005 Jul 15; 19(109):16-9. PubMed ID: 16194019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.